Results 171 to 180 of about 299,964 (312)

Clinical Validation of Four Point‐of‐Care High‐Risk HPV Assays, Including Two Reduced‐Valency Assays, for Cervical Cancer Screening in Low‐Resource Settings

International Journal of Cancer, EarlyView.
High‐risk human papillomavirus (hrHPV) testing improves cervical cancer screening by facilitating earlier detection and prevention. In low‐resource settings, however, cost and increased referrals limit its use. At the same time, many new and more affordable assays lack validation.
Neerja Bhatla, MaryLuz Rol, Seema Singhal, Showket Hussain, Anushree Patil, Pranay Tanwar, Shalini Singh, Vikrant M. Bhor, Kiran Munne, Richa Vashishtha, Shachi Vashist, Eric Lucas, Richard Muwonge, Arianis Tatiana Ramírez, Anju Singh, Vikas Khan, Jyoti Rani, Nasera Firdausi, Sandeep Sisodiya, Rutuja Wakchaure, María Alejandra Picconi, Alejandro Calderón, Margo Bell, Annemie De Smet, Alex Vorsters, Gary M. Clifford, Madhavi Chandra, Jitendra Kumar, Partha Basu   +28 more
wiley   +1 more source

Challenges and Opportunities for Improved Tuberculosis and HIV Prevention in South America. [PDF]

Open Forum Infect Dis
Quispe-Juli CU, Gallardo-Cartagena JA, Otero L, Andrade BB, Croda J, Cantos VD, Mendoza-Ticona A, Valderrama-Beltrán SL, Sequera G, Huaman MA.   +9 more
europepmc   +1 more source

Resource‐Adapted Triage Strategies for Women Testing HPV Positive With Self‐Collected Vaginal Samples in Cameroon

International Journal of Cancer, EarlyView.
Although human papillomavirus (HPV) testing is recommended for cervical cancer screening in low‐ and middle‐income countries, optimal management of HPV‐positive women remains undetermined, particularly in resource‐limited settings. Here, using data from the 3T study involving women in Cameroon, the authors evaluated the ability of extended HPV ...
Micol Murtas, Pierre Vassilakos, Ania Wisniak, Ketty Hu, Marc Arbyn, Gilles W. Tankeu Happi, Esther Abatsong, François Marcel Ndam Nsangou, Jean‐Christophe Tille, Essia Saiji, Bruno Kenfack, Patrick Petignat   +11 more
wiley   +1 more source

Background brief on the prevention benefits of HIV treatment [PDF]

The advent in 1996 of potent combination antiretroviral therapy (ART), sometimes called HAART (highly active antiretroviral therapy) or cART (effective combination antiretroviral therapy), changed the course of the HIV epidemic.

core  

Appraising the HIV prevention cascade methodology to improve HIV prevention targets: Lessons learned from a general population pilot study in east Zimbabwe. [PDF]

PLOS Glob Public Health
Moorhouse LR, Imai-Eaton JW, Maswera R, Tsenesa B, Magoge-Mandizvidza P, Moyo B, Mugurungi O, Nyamukapa C, Hallett TB, Gregson S.   +9 more
europepmc   +1 more source

HPV Testing Versus Cytology for Cervical Cancer Screening Among Women 50 Years and Older: Evidence From the HPV FOCAL Randomized Controlled Trial

International Journal of Cancer, EarlyView.
ABSTRACT Evidence on the comparative effectiveness of HPV testing versus cytology specifically in women aged ≥ 50 years who are approaching screening cessation remains limited. This analysis included 6471 women aged ≥ 50 at baseline screening in the HPV FOCAL randomized clinical trial. Women were randomly allocated to receive cytology (Control Group, n 
Md Saiful Alam, Laurie W. Smith, Lovedeep Gondara, Darrel Cook, Ruth Elwood Martin, Stuart Peacock, Lily Proctor, Gavin Stuart, David Patrick, Eduardo L. Franco, Mel Krajden, Anna Gottschlich, Gina S. Ogilvie   +12 more
wiley   +1 more source

In Vitro Pharmacokinetic Properties of MK-2048, a Potent Drug Candidate for HIV Prevention. [PDF]

Viruses
Zheng R, Valicherla GR, Graebing PW, Zhang J, Hillier SL, Rohan LC.   +5 more
europepmc   +1 more source

Follow‐Up and Outcomes After Thermal Ablation Treatment Among HIV‐Infected Women From Resource‐Limited Countries With Positive HPV‐Based Screening: Results of the AIMA‐CC Cohort (ANRS 12375)

International Journal of Cancer, EarlyView.
ABSTRACT Primary screening for human papillomavirus (HPV) followed by treatment with thermal ablation (TA) is an important component of the global strategy to eliminate cervical cancer. However, evidence on post‐TA outcomes in women living with HIV (WLWH) remains limited.
Pierre Debeaudrap, Firmin Nongodo Kabore, Limsreng Setha, Joseph Tegbe, Brahima Doukoure, Moeung Sotheara, Olivier Segeral, Korn Aun, Eugène Messou, Matthieu Chicaud, Kim Sothea, Pierre Vassilakos, Armel Poda, Evelyne Kasilé Poda, Antoine Jaquet, Adolphe Some, Patrick Petignat, Gary Clifford, Apollinaire Horo   +18 more
wiley   +1 more source

Circumcision for HIV Prevention in Men Who Have Sex With Men: An Updated Meta-Analysis. [PDF]

J Acquir Immune Defic Syndr
Davis SM, Fellows I, de Leon O, Bastani P, Hakim AJ, Toledo C, Ijeoma U, Schneider J, Lucas T, Peck M, Philpott D.   +10 more
europepmc   +1 more source

High acceptability of point‐of‐care HIV testing at the colposcopy outpatient clinic in hospitals in the Netherlands

International Journal of Gynecology &Obstetrics, Volume 169, Issue 1, Page 155-162, April 2025.
Abstract Objective Cervical cancer and its precursor are labeled as HIV indicator conditions, justifying the recommendation of HIV testing for all patients. This study aimed to assess the acceptance and patients' and gynecologists' perceptions on HIV testing in patients with cervical dysplasia at the colposcopy outpatient clinic in hospitals in the ...
R. L. O. van de Laar, C. C. E. Jordans, A. Salmaan, W. Hofhuis, S. A. H. M. van den Tillaart, I. A. M. van der Avoort, P. J. Timmers, H. J. van Beekhuizen, H. C. van Doorn, C. Rokx   +9 more
wiley   +1 more source